| abstract |
Pharmaceutically-active BHT-omega pyridyl ethers of the formula selected from BHT-omega-pyridyl ether compounds of the formula: <IMAGE> <IMAGE> wherein m=1,3 for m=1, SIGMA =6-9 for m=3, SIGMA =5-11 Sum ( SIGMA )=[m+n+1 (for oxygen)] wherein the bond between the two carbon atoms of the (CH2)n moiety most closely adjacent the pyridine ring is a single, double, or triple bond, and pharmaceutically-acceptable acid addition salts thereof, pharmaceutical compositions thereof, and a method of combating lipidemia and atherosclerosis therewith, are disclosed. |